Repaglinide–Solid Lipid Nanoparticles in Chitosan Patches for Transdermal Application: Box–Behnken Design, Characterization, and In Vivo Evaluation

References

• Holm R, Kuentz M, Ilie-Spiridon A-R, Griffin BT. Lipid based formulations as supersaturating oral delivery systems: from current to future industrial applications. Eur J Pharm Sci. 2023;189:106556. doi:10.1016/j.ejps.2023.106556
   PubMed Web of Science ®Google Scholar
• Vasam M, Maddiboyina B, Talluri C, Alagarsamy S, Gugulothu B, Roy H. Formulation, characterization, and Taguchi design study of eplerenone lipid-based solid dispersions integrated with gelucire. BioNanoScience. 2023;13(2):576–587. doi:10.1007/s12668-023-01102-4
   Web of Science ®Google Scholar
• Maddiboyina B, Nakkala RK, Roy H, Roy H. Perspectives on cutting-edge nanoparticulate drug delivery technologies based on lipids and their applications. Chem Biol Drug Des. 2023;102(2):377–394. doi:10.1111/cbdd.14230
   PubMed Web of Science ®Google Scholar
• Patravale VB, Mirani AG. Preparation and characterization of solid lipid nanoparticles-based gel for topical delivery. In: Weissig V, Elbayoumi T, editors. Pharmaceutical Nanotechnology: Basic Protocols. New York: Springer New York; 2019:293–302.
   Google Scholar
• Uner M, Yener G. Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives. Int J Nanomed. 2007;2(3):289–300.
   PubMed Web of Science ®Google Scholar
• Khames A, Khaleel MA, El-Badawy MF, El-Nezhawy AOH. Natamycin solid lipid nanoparticles - sustained ocular delivery system of higher corneal penetration against deep fungal keratitis: preparation and optimization. Int J Nanomed. 2019;14:2515–2531. doi:10.2147/IJN.S190502
   PubMed Web of Science ®Google Scholar
• Alkilani AZ, McCrudden MT, Donnelly RF. Transdermal drug delivery: innovative pharmaceutical developments based on disruption of the barrier properties of the stratum corneum. Pharmaceutics. 2015;7(4):438–470. doi:10.3390/pharmaceutics7040438
   PubMed Web of Science ®Google Scholar
• Wong WF, Ang KP, Sethi G, Looi CY. Recent advancement of medical patch for transdermal drug delivery. Medicina. 2023;59(4):778. doi:10.3390/medicina59040778
   PubMedGoogle Scholar
• Souto EB, Fangueiro JF, Fernandes AR, et al.. Physicochemical and biopharmaceutical aspects influencing skin permeation and role of SLN and NLC for skin drug delivery. Heliyon. 2022;8:e08938.
   PubMed Web of Science ®Google Scholar
• Chen MC, Ling MH, Lai KY, Pramudityo E. Chitosan microneedle patches for sustained transdermal delivery of macromolecules. Biomacromolecules. 2012;13(12):4022–4031. doi:10.1021/bm301293d
   PubMed Web of Science ®Google Scholar
• Ali HSM, Hanafy AF. Glibenclamide nanocrystals in a biodegradable chitosan patch for transdermal delivery: engineering, formulation, and evaluation. J Pharm Sci. 2017;106(1):402–410. doi:10.1016/j.xphs.2016.10.010
   PubMed Web of Science ®Google Scholar
• Karami Z, Saghatchi Zanjani MR, Nasihatsheno N, Hamidi M. Improved oral bioavailability of repaglinide, a typical BCS Class II drug, with a chitosan-coated nanoemulsion. J Biomed Mater Res B. 2020;108(3):717–728. doi:10.1002/jbm.b.34426
   Web of Science ®Google Scholar
• Gadadare R, Mandpe L, Pokharkar V. Ultra rapidly dissolving repaglinide nanosized crystals prepared via bottom-up and top-down approach: influence of food on pharmacokinetics behavior. AAPS Pharm Sci Tech. 2015;16(4):787–799. doi:10.1208/s12249-014-0267-8
   PubMed Web of Science ®Google Scholar
• Zhu Z, Yang T, Zhao Y, Gao N, Leng D, Ding P. A simple method to improve the dissolution of repaglinide and exploration of its mechanism. Asian J. Pharm. Sci. 2014;9(4):218–225. doi:10.1016/j.ajps.2014.06.004
   Google Scholar
• Fouad SA, Teaima MH, Gebril MI, Abd Allah FI, El-Nabarawi MA, Elhabal SF. Formulation of novel niosomal repaglinide chewable tablets using coprocessed excipients: in vitro characterization, optimization and enhanced hypoglycemic activity in rats. Drug Delivery. 2023;30(1):2181747. doi:10.1080/10717544.2023.2181747
   PubMed Web of Science ®Google Scholar
• Liu M, Cao W, Sun Y, He Z. Preparation, characterization and in vivo evaluation of formulation of repaglinide with hydroxypropyl-β-cyclodextrin. Int J Pharm. 2014;477(1–2):159–166. doi:10.1016/j.ijpharm.2014.10.038
   PubMedGoogle Scholar
• Chang C, Bahadduri PM, Polli JE, Swaan PW, Ekins S. Rapid identification of P-glycoprotein substrates and inhibitors. Drug Metab Dispos. 2006;34(12):1976–1984. doi:10.1124/dmd.106.012351
   PubMed Web of Science ®Google Scholar
• Rawat MK, Jain A, Mishra A, Muthu MS, Singh S. Development of repaglinide loaded solid lipid nanocarrier: selection of fabrication method. Curr Drug Deliv. 2010;7(1):44–50. doi:10.2174/156720110790396472
   PubMedGoogle Scholar
• Lokhande AB, Mishra S, Kulkarni RD, Naik JB. Preparation and characterization of repaglinide loaded ethylcellulose nanoparticles by solvent diffusion technique using high pressure homogenizer. J Pharm Res. 2013;7(5):421–426. doi:10.1016/j.jopr.2013.04.049
   Google Scholar
• Navamanisubramanian R, Nerella R, Duraipandian C, Seetharaman S. Quality by design approach for optimization of repaglinide buccal tablets using box-behnken design. Future J Pharm Sci. 2018;4(2):265–272. doi:10.1016/j.fjps.2018.10.002
   Google Scholar
• He W, Wu M, Huang S, Yin L. Matrix tablets for sustained release of repaglinide: preparation, pharmacokinetics and hypoglycemic activity in beagle dogs. Int J Pharm. 2015;478(1):297–307. doi:10.1016/j.ijpharm.2014.11.059
   PubMedGoogle Scholar
• Tavakoli N, Minaiyan M, Tabbakhian M, Pendar Y. Preparation and evaluation of a controlled drug release of repaglinide through matrix pellets: in vitro and in vivo studies. J Microencapsul. 2014;31(6):529–534. doi:10.3109/02652048.2014.885604
   PubMed Web of Science ®Google Scholar
• Qin C, He W, Zhu C, et al.. Controlled release of metformin hydrochloride and repaglinide from sandwiched osmotic pump tablet. Int J Pharm. 2014;466(1–2):276–285. doi:10.1016/j.ijpharm.2014.03.002
   PubMedGoogle Scholar
• Engla G, Soni LK, Dixit VK. Sustained release delivery of repaglinide by biodegradable microspheres. J Drug Delivery Ther. 2017;7:77–80.
   Google Scholar
• Shinde UA, Modani SH, Singh KH. Design and development of repaglinide microemulsion gel for transdermal delivery. AAPS Pharm Sci Tech. 2018;19(1):315–325. doi:10.1208/s12249-017-0811-4
   PubMed Web of Science ®Google Scholar
• Beg S, Akhter S. Box–behnken designs and their applications in pharmaceutical product development. In: Beg S, editor. Design of Experiments for Pharmaceutical Product Development: Volume I : Basics and Fundamental Principles. Singapore: Springer Singapore; 2021:77–85.
   Google Scholar
• Marasini N, Yan YD, Poudel BK, Choi HG, Yong CS, Kim JO. Development and optimization of self‐nanoemulsifying drug delivery system with enhanced bioavailability by box–behnken design and desirability function. J Pharmaceut Sci. 2012;101(12):4584–4596. doi:10.1002/jps.23333
   PubMed Web of Science ®Google Scholar
• Usta DY, Timur B, Teksin ZS. Formulation development, optimization by Box-Behnken design, characterization, in vitro, ex-vivo, and in vivo evaluation of bosentan-loaded self-nanoemulsifying drug delivery system: a novel alternative dosage form for pulmonary arterial hypertension treatment. Eur J Pharm Sci. 2022;174:106159. doi:10.1016/j.ejps.2022.106159
   PubMed Web of Science ®Google Scholar
• Parmar K, Patel J, Sheth N. Self nano-emulsifying drug delivery system for Embelin: design, characterization and in-vitro studies. Asian J Pharm Sci. 2015;10(5):396–404. doi:10.1016/j.ajps.2015.04.006
   Web of Science ®Google Scholar
• Abla KK, Mneimneh AT, Allam AN, Mehanna MM. Application of Box-Behnken design in the preparation, optimization, and in-vivo pharmacokinetic evaluation of oral tadalafil-loaded niosomal film. Pharmaceutics. 2023;15(1):173. doi:10.3390/pharmaceutics15010173
   PubMed Web of Science ®Google Scholar
• Kumar S, Narayan R, Ahammed V, Nayak Y, Naha A, Nayak UY. Development of ritonavir solid lipid nanoparticles by Box Behnken design for intestinal lymphatic targeting. J Drug Delivery Sci Technol. 2018;44:181–189. doi:10.1016/j.jddst.2017.12.014
   Web of Science ®Google Scholar
• Nazem Z, Firoozian F, Khodabandelou S, Mohammadi M, Mahboobian MM. Systematic optimization of solid lipid nanoparticles of silybin for improved oral drug delivery by Box-Behnken design: in vitro and in vivo evaluations. J Pharm Innovation. 2022;1:2
   Google Scholar
• El-Say KM, Hosny KM, Ahmad A. Optimization of carvedilol solid lipid nanoparticles: an approach to control the release and enhance the oral bioavailability on rabbits. PLoS One. 2018;13(8):e0203405. doi:10.1371/journal.pone.0203405
   PubMed Web of Science ®Google Scholar
• Hou S, Hindle M, Byron PR. A stability-indicating HPLC assay method for budesonide. J Pharm Biomed Analysis. 2001;24(3):371–380. doi:10.1016/S0731-7085(00)00424-6
   PubMed Web of Science ®Google Scholar
• Das S, Ng WK, Kanaujia P, Kim S, Tan RBH. Formulation design, preparation and physicochemical characterizations of solid lipid nanoparticles containing a hydrophobic drug: effects of process variables. Colloids Surf b. 2011;88(1):483–489. doi:10.1016/j.colsurfb.2011.07.036
   PubMed Web of Science ®Google Scholar
• Nair AB, Shah J, Al-Dhubiab BE, et al.. Clarithromycin solid lipid nanoparticles for topical ocular therapy: optimization, evaluation and in vivo studies. Pharmaceutics. 2021;13:523. doi:10.3390/pharmaceutics13040523
   PubMed Web of Science ®Google Scholar
• Ghadiri M, Fatemi S, Vatanara A, et al.. Loading hydrophilic drug in solid lipid media as nanoparticles: statistical modeling of entrapment efficiency and particle size. Int J Pharm. 2012;424(1–2):128–137. doi:10.1016/j.ijpharm.2011.12.037
   PubMed Web of Science ®Google Scholar
• Yadav P, Rastogi V, Verma A. Application of Box–Behnken design and desirability function in the development and optimization of self-nanoemulsifying drug delivery system for enhanced dissolution of ezetimibe. Future J Pharm Sci. 2020;6(1):7. doi:10.1186/s43094-020-00023-3
   Web of Science ®Google Scholar
• Howard MD, Lu X, Jay M, Dziubla TD. Optimization of the lyophilization process for long-term stability of solid-lipid nanoparticles. Drug Dev Ind Pharm. 2012;38(10):1270–1279. doi:10.3109/03639045.2011.645835
   PubMed Web of Science ®Google Scholar
• Ullah W, Nawaz A, Akhlaq M, et al.. Transdermal delivery of gatifloxacin carboxymethyl cellulose-based patches: preparation and characterization. J Drug Delivery Sci Technol. 2021;66:102783. doi:10.1016/j.jddst.2021.102783
   Web of Science ®Google Scholar
• Kumar R, Sinha VR, Dahiya L, Sarwal A. Transdermal delivery of duloxetine-sulfobutylether-β-cyclodextrin complex for effective management of depression. Int J Pharm. 2021;594:120129. doi:10.1016/j.ijpharm.2020.120129
   PubMedGoogle Scholar
• Malaiya MK, Jain A, Pooja H, Jain A, Jain D. Controlled delivery of rivastigmine using transdermal patch for effective management of Alzheimer’s disease. J Drug Delivery Sci Technol. 2018;45:408–414. doi:10.1016/j.jddst.2018.03.030
   Web of Science ®Google Scholar
• Mutalik S, Udupa N. Glibenclamide transdermal patches: physicochemical, pharmacodynamic, and pharmacokinetic evaluations. J Pharmaceut Sci. 2004;93(6):1577–1594. doi:10.1002/jps.20058
   PubMed Web of Science ®Google Scholar
• Rehman M, Ihsan A, Madni A, et al.. Solid lipid nanoparticles for thermoresponsive targeting: evidence from spectrophotometry, electrochemical, and cytotoxicity studies. Int J Nanomed. 2017;12:8325–8336. doi:10.2147/IJN.S147506
   PubMed Web of Science ®Google Scholar
• Zhao K, Singh J. In vitro percutaneous absorption enhancement of propranolol hydrochloride through porcine epidermis by terpenes/ethanol. J Control Release. 1999;62(3):359–366. doi:10.1016/S0168-3659(99)00171-6
   PubMed Web of Science ®Google Scholar
• Thakur G, Singh A, Singh I. Formulation and evaluation of transdermal composite films of chitosan-montmorillonite for the delivery of curcumin. Int J Pharm Investig. 2016;6(1):23–31. doi:10.4103/2230-973X.176468
   PubMed Web of Science ®Google Scholar
• Pervaiz F, Saba A, Yasin H, et al.. Fabrication of solid lipid nanoparticles-based patches of paroxetine and their ex-vivo permeation behaviour. Artif Cells Nanomed Biotechnol. 2023;51(1):108–119. doi:10.1080/21691401.2023.2179631
   PubMed Web of Science ®Google Scholar
• Can A, Erdal M, Güngör S, Özsoy Y. Optimization and Characterization of Chitosan Films for Transdermal Delivery of Ondansetron. Molecules. 2013;18(5):5455. doi:10.3390/molecules18055455
   PubMed Web of Science ®Google Scholar
• Kim JD, Kang SM, Seo BI, Choi HY, Choi HS, Ku SK. Anti-diabetic activity of SMK001, a poly herbal formula in streptozotocin induced diabetic rats: therapeutic study. Biol Pharm Bull. 2006;29(3):477–482. doi:10.1248/bpb.29.477
   PubMed Web of Science ®Google Scholar
• Fayyad MK, Ghanem EH. Liquid chromatography tandem mass spectrometry method for determination of anti-diabetic drug repaglinide in human plasma. Am J Anal Chem. 2014;05(04):12. doi:10.4236/ajac.2014.54035
   Google Scholar
• Duong VA, Nguyen TTL, Maeng HJ. Preparation of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for Drug Delivery and the Effects of Preparation Parameters of Solvent Injection Method. Molecules. 2020;25(20):4781. doi:10.3390/molecules25204781
   PubMed Web of Science ®Google Scholar
• Patere SN, Desai NS, Jain AS, et al.. Compritol®888 ATO a lipid excipient for sustained release of highly water soluble active: formulation, scale-up and IVIVC study. Curr Drug Deliv. 2013;10(5):548–556. doi:10.2174/1567201811310050006
   PubMed Web of Science ®Google Scholar
• Shah M, Chuttani K, Mishra AK, Pathak K. Oral solid compritol 888 ATO nanosuspension of simvastatin: optimization and biodistribution studies. Drug Dev. Ind. Pharm. 2011;37(5):526–537. doi:10.3109/03639045.2010.527983
   PubMed Web of Science ®Google Scholar
• Renukuntla J, Peterson-Sockwell S, Clark BA, et al.. Design and preclinical evaluation of nicotine–stearic acid conjugate-loaded solid lipid nanoparticles for transdermal delivery: a technical note. Pharmaceutics. 2023;15(4):1043. doi:10.3390/pharmaceutics15041043
   PubMed Web of Science ®Google Scholar
• Müller RH, Mäder K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. Eur J Pharm Biopharm. 2000;50(1):161–177. doi:10.1016/S0939-6411(00)00087-4
   PubMed Web of Science ®Google Scholar
• Azhar Shekoufeh Bahari L, Hamishehkar H. The impact of variables on particle size of solid lipid nanoparticles and nanostructured lipid carriers; a comparative literature review. Adv Pharm Bull. 2016;6(2):143–151. doi:10.15171/apb.2016.021
   PubMedGoogle Scholar
• Seo JW, Kim KJ, Kim SH, Hwang KM, Seok SH, Park ES. Effect of process parameters on formation and aggregation of nanoparticles prepared with a shirasu porous glass membrane. Chem Pharm Bull. 2015;63(10):792–798. doi:10.1248/cpb.c15-00297
   PubMed Web of Science ®Google Scholar
• Bolla PK, Kalhapure RS, Rodriguez VA, Ramos DV, Dahl A, Renukuntla J. Preparation of solid lipid nanoparticles of furosemide-silver complex and evaluation of antibacterial activity. J Drug Delivery Sci Technol. 2019;49:6–13. doi:10.1016/j.jddst.2018.10.035
   Web of Science ®Google Scholar
• Emami J, Mohiti H, Hamishehkar H, Varshosaz J. Formulation and optimization of solid lipid nanoparticle formulation for pulmonary delivery of budesonide using Taguchi and Box-Behnken design. Res Pharm Sci. 2015;10:17–33.
   PubMed Web of Science ®Google Scholar
• Danaei M, Dehghankhold M, Ataei S, et al.. Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier Systems. Pharmaceutics. 2018;4:10.
   Google Scholar
• Thakkar HP, Desai JL, Parmar MP. Application of Box-Behnken design for optimization of formulation parameters for nanostructured lipid carriers of candesartan cilexetil. Asian J Pharm. 2014;3:8.
   Google Scholar
• Sinsuebpol C, Changsan N. Effects of ultrasonic operating parameters and emulsifier system on sacha inchi oil nanoemulsion characteristics. J Oleo Sci. 2020;69(5):437–448. doi:10.5650/jos.ess19193
   PubMed Web of Science ®Google Scholar
• Cheng Q, Debnath S, Gregan E, Byrne HJ. Ultrasound-assisted SWNTs dispersion: effects of sonication parameters and solvent properties. J Phys Chem C. 2010;114(19):8821–8827. doi:10.1021/jp101431h
   Web of Science ®Google Scholar
• Leong TS, Wooster TJ, Kentish SE, Ashokkumar M. Minimising oil droplet size using ultrasonic emulsification. Ultrason Sonochem. 2009;16(6):721–727. doi:10.1016/j.ultsonch.2009.02.008
   PubMed Web of Science ®Google Scholar
• Dhiman N, Awasthi R, Sharma B, Kharkwal H, Kulkarni GT. Lipid nanoparticles as carriers for bioactive delivery. Front Chem. 2021;9:580118. doi:10.3389/fchem.2021.580118
   PubMed Web of Science ®Google Scholar
• Yang -Y-Y, Chung T-S, Bai X-L, Chan W-K. Effect of preparation conditions on morphology and release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion method. Chem Eng Sci. 2000;55(12):2223–2236. doi:10.1016/S0009-2509(99)00503-5
   Web of Science ®Google Scholar
• Hao J, Fang X, Zhou Y, et al.. Development and optimization of solid lipid nanoparticle formulation for ophthalmic delivery of chloramphenicol using a Box-Behnken design. Int J Nanomed. 2011;6:683–692. doi:10.2147/IJN.S17386
   PubMed Web of Science ®Google Scholar
• Qadir A, Aqil M, Ali A, et al.. Nanostructured lipidic carriers for dual drug delivery in the management of psoriasis: systematic optimization, dermatokinetic and preclinical evaluation. J Drug Delivery Sci Technol. 2020;57:101775. doi:10.1016/j.jddst.2020.101775
   Web of Science ®Google Scholar
• Agrawal M, Saraf S, Pradhan M, Patel RJ, Singhvi G, Alexander A. Design and optimization of curcumin loaded nano lipid carrier system using Box-Behnken design. Biomed Pharmacother. 2021;141:111919. doi:10.1016/j.biopha.2021.111919
   PubMed Web of Science ®Google Scholar
• Li Y, Zhao X, Zu Y, Zhang Y. Preparation and characterization of paclitaxel nanosuspension using novel emulsification method by combining high speed homogenizer and high pressure homogenization. Int J Pharm. 2015;490(1–2):324–333. doi:10.1016/j.ijpharm.2015.05.070
   PubMedGoogle Scholar
• Kumar M, Sharma G, Singla D, et al.. Enhanced oral absorption of all-trans retinoic acid upon encapsulation in solid lipid nanoparticles. Pharm Nanotechnol. 2020;8(6):495–510. doi:10.2174/2211738508999201027220825
   PubMedGoogle Scholar
• Avasatthi V, Pawar H, Dora CP, Bansod P, Gill MS, Suresh S. A novel nanogel formulation of methotrexate for topical treatment of psoriasis: optimization, in vitro and in vivo evaluation. Pharm Dev Technol. 2016;21(5):554–562. doi:10.3109/10837450.2015.1026605
   PubMed Web of Science ®Google Scholar
• Ammar H, Salama H, El-Nahhas S, Elmotasem H. Design and evaluation of chitosan films for transdermal delivery of glimepiride. Current Drug Deliv. 2008;5(4):290–298. doi:10.2174/156720108785915005
   PubMedGoogle Scholar
• Roy H, Nayak BS, Nandi S. Chitosan anchored nanoparticles in current drug development utilizing computer-aided pharmacokinetic modeling: case studies for target specific cancer treatment and future prospective. Curr Pharm Des. 2020;26(15):1666–1675. doi:10.2174/1381612826666200203121241
   PubMed Web of Science ®Google Scholar
• Tejada G, Barrera MG, Piccirilli GN, et al.. Development and evaluation of buccal films based on chitosan for the potential treatment of oral candidiasis. AAPS Pharm Sci Tech. 2017;18(4):936–946. doi:10.1208/s12249-017-0720-6
   PubMed Web of Science ®Google Scholar
• Rao H, Ahmad S, Madni A, et al.. Compritol-based alprazolam solid lipid nanoparticles for sustained release of alprazolam: preparation by hot melt encapsulation. Molecules. 2022;28(1):27. doi:10.3390/molecules28010027
   PubMedGoogle Scholar
• Danyuo Y, Ani CJ, Salifu AA, et al.. Anomalous release kinetics of prodigiosin from poly-n-isopropyl-acrylamid based hydrogels for the treatment of triple negative breast cancer. Sci Rep. 2019;9(1):3862. doi:10.1038/s41598-019-39578-4
   PubMedGoogle Scholar
• Arora R, Katiyar SS, Kushwah V, Jain S. Solid lipid nanoparticles and nanostructured lipid carrier-based nanotherapeutics in treatment of psoriasis: a comparative study. Expert Opin Drug Deliv. 2017;14(2):165–177. doi:10.1080/17425247.2017.1264386
   PubMed Web of Science ®Google Scholar
• Choi WI, Lee JH, Kim J-Y, Kim J-C, Kim YH, Tae G. Tae G: efficient skin permeation of soluble proteins via flexible and functional nano-carrier. J Control Release. 2012;157(2):272–278. doi:10.1016/j.jconrel.2011.08.013
   PubMed Web of Science ®Google Scholar
• Elkomy MH, Ali AA, Eid HM. Chitosan on the surface of nanoparticles for enhanced drug delivery: a comprehensive review. J Control Release. 2022;351:923–940. doi:10.1016/j.jconrel.2022.10.005
   PubMed Web of Science ®Google Scholar
• Wissing SA. Cosmetic applications for solid lipid nanoparticles (SLN). Int J Pharm. 2003;254(1):65–68. doi:10.1016/S0378-5173(02)00684-1
   PubMed Web of Science ®Google Scholar
• Müller RH, Radtke M, Wissing SA. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Delivery Rev. 2002;54:S131–S155. doi:10.1016/S0169-409X(02)00118-7
   PubMed Web of Science ®Google Scholar
• Jenning V, Gysler A, Schäfer-Korting M, Gohla SH. Vitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skin. Eur J Pharm Biopharm. 2000;49(3):211–218. doi:10.1016/S0939-6411(99)00075-2
   PubMed Web of Science ®Google Scholar